Cipher Pharmaceuticals Total Liabilities

Cipher Pharmaceuticals (CPHRF) currently reports a total liabilities of $20M as of June 2026. That compares with $43M in the prior-year period — down 54.3% year over year. Use the charts on this page to explore Cipher Pharmaceuticals's total liabilities history and peer comparisons.

Cipher Pharmaceuticals's total liabilities decreased from $43M to $20M — a 54.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cipher Pharmaceuticals reported $20M in total liabilities as of June 2026. That compares with $43M in the prior-year period — down 54.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $20M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cipher Pharmaceuticals, and consider following CPHRF for alerts when major investors trade the stock.

Cipher Pharmaceuticals is classified in the Healthcare sector. On total liabilities, it currently shows $20M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CPHRF with unrelated industries.